← Evidence map

ArticleCells2025

Therapeutic Potential of Emricasan, a Pan-Caspase Inhibitor, in Reducing Cell Death and Extracellular Matrix Accumulation in Fuchs Endothelial Corneal Dystrophy.

Sohya Fujimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40214452